U.S. Markets closed
  • S&P Futures

    4,699.25
    +0.25 (+0.01%)
     
  • Dow Futures

    35,747.00
    +1.00 (+0.00%)
     
  • Nasdaq Futures

    16,390.75
    -1.50 (-0.01%)
     
  • Russell 2000 Futures

    2,269.80
    0.00 (0.00%)
     
  • Crude Oil

    72.74
    +0.38 (+0.53%)
     
  • Gold

    1,784.50
    -1.00 (-0.06%)
     
  • Silver

    22.40
    -0.04 (-0.16%)
     
  • EUR/USD

    1.1339
    -0.0005 (-0.0454%)
     
  • 10-Yr Bond

    1.5090
    +0.0290 (+1.96%)
     
  • Vix

    19.90
    -1.99 (-9.09%)
     
  • GBP/USD

    1.3203
    -0.0004 (-0.0277%)
     
  • USD/JPY

    113.7230
    -0.0140 (-0.0123%)
     
  • BTC-USD

    49,938.28
    -765.73 (-1.51%)
     
  • CMC Crypto 200

    1,306.68
    +1.56 (+0.12%)
     
  • FTSE 100

    7,337.05
    -2.85 (-0.04%)
     
  • Nikkei 225

    28,810.58
    -50.04 (-0.17%)
     

Better Buy: Ocugen or Novavax?

·4 min read
Better Buy: Ocugen or Novavax?
In this article:
  • Oops!
    Something went wrong.
    Please try again later.
  • Oops!
    Something went wrong.
    Please try again later.

There may be a second wave of COVID-19 vaccines coming. With the hopes of widespread approval of each company's SARS-CoV-2 vaccine, Novavax (NASDAQ: NVAX) is already up nearly 90% year to date while Ocugen (NASDAQ: OCGN) is up over 300% in the same time frame. Patrick Bafuma: To begin, let's take a look at Novavax.